Editorial: Bladder Cancer – A Cinderella Cancer: Advances and Remaining Research Questions

• Mieke Van Hemelrijck,
• Prashant Patel,
• Kent W. Mouw

Affiliations

Mieke Van Hemelrijck

School of Cancer and Pharmaceutical Sciences, Translational Oncology and Urology Research (TOUR), King's College London, London, United Kingdom

Prashant Patel

Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

Kent W. Mouw

Department of Radiation Oncology, Dana–Farber Cancer Institute/Brigham & Women's Hospital and Harvard Medical School, Boston, MA, United States